Literature DB >> 16819515

ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein.

S-L Chen1, S-T Lin, T-C Tsai, W-C Hsiao, Y-P Tsao.   

Abstract

Human papillomavirus type 16 E5 (HPV-16 E5) is a highly hydrophobic membrane protein with weak-transforming activity, which is associated with ErbB4 receptor in HPV-16-infected cervical lesions. Presently, we investigated the transforming mechanisms of E5 involving ErbB4 signaling. Firstly, we report a role for ErbB4 (JM-b/CYT-1) receptor that activates c-jun gene expression and phosphorylating at Ser63 and Ser73 of the c-Jun protein in ligand-independent and Ras-c-jun NH(2)-terminal kinase-dependent pathway. Secondly, we show that HPV-16 E5 protein can form a complex with ErbB4 via binding to the extracellular and transmembrane domains of ErbB4 (JM-b/CYT-1). When co-expressing HPV-16 E5 and ErbB4 in cells, E5 can abrogate ErbB4-induced c-Jun protein expression and phosphorylation resulted in increasing cell proliferation compared to ErbB4-expressing cells. The interaction between of HPV-16 E5 and ErbB4 provides more insight into the mechanisms of HPV-16 E5 transformation induction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819515     DOI: 10.1038/sj.onc.1209768

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients.

Authors:  Dai-Wei Liu; Yuh-Cheng Yang; Ho-Fan Lin; Mei-Fang Lin; Ya-Wen Cheng; Chen-Chung Chu; Yeou-Ping Tsao; Show-Li Chen
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

2.  Membrane orientation of the human papillomavirus type 16 E5 oncoprotein.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Sawali R Sudarshan; Richard Schlegel
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

Review 3.  Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.

Authors:  Niladri Ganguly
Journal:  Cell Oncol (Dordr)       Date:  2012-01-20       Impact factor: 6.730

4.  The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes.

Authors:  Sawali R Sudarshan; Richard Schlegel; Xuefeng Liu
Journal:  Biochem Biophys Res Commun       Date:  2010-08-03       Impact factor: 3.575

Review 5.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

6.  The human papillomavirus type 16 E5 oncoprotein translocates calpactin I to the perinuclear region.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Jess D Hebert; Christopher M Kamonjoh; Richard Schlegel
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

7.  Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein.

Authors:  Ewa Krawczyk; John A Hanover; Richard Schlegel; Frank A Suprynowicz
Journal:  Biochem Biophys Res Commun       Date:  2008-05-01       Impact factor: 3.575

8.  Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Xuefeng Liu; Yuhai Dai; Dan P Hartmann; John Hanover; Richard Schlegel
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

9.  Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer.

Authors:  Duanduan Ma; Raymond L Hovey; Zhengyan Zhang; Samantha Fye; Phyllis C Huettner; Ingrid B Borecki; Janet S Rader
Journal:  Gynecol Oncol       Date:  2013-08-06       Impact factor: 5.482

Review 10.  The E5 proteins.

Authors:  Daniel DiMaio; Lisa M Petti
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.